In lung adenocarcinomas, the S1P-S1P3 signaling upregulates EGFR and enhances EGFR-mediated carcinogenic activities contributing to tumorigenesis or progression of lung adenocarcinomas [29]. Here, EGFR is linked to lung adenocarcinoma.